Photo: Sartorius

ACTIP member companies

AmatsiQBiologicals – Belgium
Bayer Pharma AG
– Germany
BE Vaccines – France
Biogen – Denmark
BioInvent International AB – Sweden
BioMarin – Ireland
BioReliance – United Kingdom
Boehringer Ingelheim Pharma GmbH KG & Co. KG – Germany
Clean Cells – France
CSL Behring-Germany
Eli Lilly S.A. – Ireland
ExcellGene SA – Switzerland
ExpreS²ion Biotechnologies – Denmark
GE Healthcare – Sweden
Genzyme Sanofi – Belgium
Glycotope Biotechnology GmbH – Germany
GSK Vaccines – Germany
Glenmark Pharmaceuticals S.A. – Switzerland
Janssen Infectious Diseases and Vaccines – The Netherlands
LONZA Biologics – United Kingdom
MedImmune – United Kingdom

Merck Life Science – Germany
Merck Serono
– Switzerland
MorphoSys AG
– Germany
MSD
– The Netherlands
Novasep – Belgium
NovImmune SA – Switzerland
Novo Nordisk A/S – Denmark
Pall LifeSciences – Belgium
Patheon-Biologics – The Netherlands
Polpharma Biologics – Poland
Rentschler Biopharma SE – Germany
Roche Diagnostics GmbH – Germany
Sanofi-Aventis – Germany
Sartorius Stedim Cellca GmbH – Germany
Swedish Orphan Biovitrum – Sweden
Symphogen A/S – Denmark
Synthon – The Netherlands
Teva Biotech – Germany
4Tune Engineering – Portugal
UCB – Switzerland
UniQure -The Netherlands
Valneva – France

Honorary Members

Prof. Dr. Michael Comer – Ireland
Dr. Helma Hermans – Spain

Observers

Services of the European Commission DG Research: Dr. Jürgen Sautter

European Society for Animal Cell Technology, ESACT Chairman:
Prof. Dr. Paula M. Alves, iBET

How to become a member

ACTIP membership is open to companies located in Europe, engaged in industrial use of animal cell culture for production of proteins and/or other substances, the production of vaccines or involved in gene therapy. Furthermore, the company should be making significant research and development efforts in one or all of these fields.
A company wishing to apply for membership should contact the ACTIP secretariat on how to present itself. Membership applications are voted on by the members during the next plenary meeting.

©2017 ACTIP

Log in with your credentials

Forgot your details?